John Oyler, Chief Executive Officer at BeiGene, Ltd. (BGNE), sold 2,265 shares at $159.91 ($361K) on 2024-06-17, disclosed to the SEC on 2024-06-20.
Seasonal sale ($361k) by Chief Executive Officer — this insider has traded BGNE in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $158.53 | 297 | $47K | 13.0% |
| 2 | $159.40 | 608 | $97K | 26.8% |
| 3 | $159.40 | 608 | $97K | 26.8% |
| 4 | $159.91 | 376 | $60K | 16.6% |
| 5 | $159.91 | 376 | $60K | 16.6% |
| Total | $159.46 avg | 2,265 |
| $361K |
| 100% |
| Filing → |
| ONC | SELL | 2026-07-17 | $89.4M | — | Filing → |
| ONC | SELL | 2026-07-17 | $20.2M | — | Filing → |
| ONC | SELL | 2026-07-14 | $44.6M | — | Filing → |